🚨 Statins & Diabetes: Dose Matters, But So Does Perspective 💊📉

A 2024 CTT Collaboration meta-analysis of 154,664 participants confirms:

✅ Statins modestly increase risk of diabetes (10% with moderate, 36% with high-intensity)

📈 Small upticks in HbA1c and glucose

🧪 But most new cases were already teetering near the threshold

🩺 Bottom line? Cardiovascular benefits far outweigh the diabetes risk.

💡 It's a reminder: precision prevention is about balancing risk, not eliminating it.

📚 Ref: Lancet Diabetes Endocrinol 2024 | DOI: 10.1016/S2213-8587(24)00040-8

#Statins #Diabetes #Cardiology #EvidenceBasedMedicine #Prevention #Lipids #RCT #CTTCollaboration #BalancingBenefits #MedicalResearch